Funding · Company
Delfi Diagnostics, Inc.
Baltimore, MDBiotech & Pharma
Delfi Diagnostics, Inc. of Baltimore, MD has disclosed $259M across 2 Form D offerings filed with the SEC between Jul 25, 2022 and Dec 18, 2025.
$259M
Total disclosed
2
Form D offerings
9
Open roles today
Hiring — 9 open roles as of Sep 23, 2026
Mostly Research & Development (2), Lab Operations (2), Accounting (1). Based in Palo Alto, CA, Remote. Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$34M
Form D · Dec 18, 2025 ↗
Q4 2025
· target $60M
Filing details
HeadquartersBaltimore, MDIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001783735Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →